Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Leukemia, Myeloid, Acute 38Neoplasm Metastasis 37Multiple Myeloma 29Lymphoma 23Colorectal Neoplasms 18Breast Neoplasms 18Pancreatic Neoplasms 17Prostatic Neoplasms 16Myelodysplastic Syndromes 16Lymphoma, Large B-Cell, Diffuse 15Lung Neoplasms 15Leukemia, Lymphocytic, Chronic, B-Cell 15Burkitt Lymphoma 15Triple Negative Breast Neoplasms 13Melanoma 13Precursor Cell Lymphoblastic Leukemia-Lymphoma 12Ovarian Neoplasms 12Carcinoma, Non-Small-Cell Lung 12Sarcoma 10Neuroblastoma 9Neoplasms 9Glioma 9Carcinoma, Renal Cell 9Squamous Cell Carcinoma of Head and Neck 8Lymphoma, T-Cell 8Leukemia, Biphenotypic, Acute 8Fallopian Tube Neoplasms 8Endometrial Neoplasms 8Myeloproliferative Disorders 7Lymphoma, Non-Hodgkin 7

Interventions

Specimen Handling 6Tamoxifen 4ruxolitinib 1pembrolizumab 1exemestane 1Watchful Waiting 1Surveys and Questionnaires 1Starch 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Radiotherapy 1Radiation Dose Hypofractionation 1Radiation 1Protons 1Proton Therapy 1Omacor 1Observation 1Methods 1Metformin 1Magnetic Resonance Spectroscopy 1Letrozole 1Laser Therapy 1Interviews as Topic 1Hypnosis, Anesthetic 1Genotype 1Educational Status 1Early Intervention, Educational 1Decision Support Techniques 1Counseling 1Cannabidiol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Breast Carcinoma In Situ × Biopsy × 90 days × Clear all
NCT06184750 2026-05-13

Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial

National Cancer Institute (NCI)

Phase 2 Recruiting
200 enrolled
Breast

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡